154 related articles for article (PubMed ID: 2457431)
1. Interferon effects upon the adenocarcinoma 38 and HL-60 cell lines: antiproliferative responses and synergistic interactions with halogenated pyrimidine antimetabolites.
Elias L; Crissman HA
Cancer Res; 1988 Sep; 48(17):4868-73. PubMed ID: 2457431
[TBL] [Abstract][Full Text] [Related]
2. Interaction of gamma interferon and 5-fluorouracil in the H630 human colon carcinoma cell line.
Chu E; Zinn S; Boarman D; Allegra CJ
Cancer Res; 1990 Sep; 50(18):5834-40. PubMed ID: 1697502
[TBL] [Abstract][Full Text] [Related]
3. Biochemical mechanisms of interferon modulation of 5-fluorouracil activity in colon cancer cells.
van der Wilt CL; Smid K; Aherne GW; Noordhuis P; Peters GJ
Eur J Cancer; 1997 Mar; 33(3):471-8. PubMed ID: 9155534
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of interaction between interferon-gamma and antineoplastic agent on the differentiation of HL-60 promyelocytic cells.
Kafka M; Dvilansky A; Nathan I
Exp Hematol; 1990 Mar; 18(3):153-8. PubMed ID: 2105896
[TBL] [Abstract][Full Text] [Related]
5. Isolation and characterization of a human ileocecal carcinoma cell line (HCT-8) subclone resistant to fluorodeoxyuridine.
Zhang ZG; Malmberg M; Yin MB; Slocum HK; Rustum YM
Biochem Pharmacol; 1993 Mar; 45(5):1157-64. PubMed ID: 8461045
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of interaction of interferon and 5-fluorouracil in solid tumors.
Neefe JR; John W
Semin Oncol; 1991 Oct; 18(5 Suppl 7):77-82. PubMed ID: 1719644
[TBL] [Abstract][Full Text] [Related]
7. The effects of gamma-interferon combined with 5-fluorouracil or 5-fluoro-2'-deoxyuridine on proliferation and antigen expression in a panel of human colorectal cancer cell lines.
Maas IW; Boven E; Pinedo HM; Schlüper HM; Haisma HJ
Int J Cancer; 1991 Jul; 48(5):749-56. PubMed ID: 1830034
[TBL] [Abstract][Full Text] [Related]
8. Biochemical modulation of 5-fluorouracil with murine interferon-alpha/beta against murine renal cell carcinoma.
Marumo K; Oya M; Murai M
Int J Urol; 1997 Mar; 4(2):163-8. PubMed ID: 9179690
[TBL] [Abstract][Full Text] [Related]
9. Thymidine kinase, thymidylate synthase, and dihydropyrimidine dehydrogenase profiles of cell lines of the National Cancer Institute's Anticancer Drug Screen.
Grem JL; Danenberg KD; Behan K; Parr A; Young L; Danenberg PV; Nguyen D; Drake J; Monks A; Allegra CJ
Clin Cancer Res; 2001 Apr; 7(4):999-1009. PubMed ID: 11309351
[TBL] [Abstract][Full Text] [Related]
10. Interferon effects upon fluorouracil metabolism by HL-60 cells.
Elias L; Sandoval JM
Biochem Biophys Res Commun; 1989 Sep; 163(2):867-74. PubMed ID: 2783128
[TBL] [Abstract][Full Text] [Related]
11. Locus of the interaction among 5-fluorouracil, leucovorin, and interferon-alpha 2a in colon carcinoma cells.
Houghton JA; Morton CL; Adkins DA; Rahman A
Cancer Res; 1993 Sep; 53(18):4243-50. PubMed ID: 8364921
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of 5-fluoro-2'-deoxyuridine antineoplastic activity by 5-benzyloxybenzyloxybenzylacyclouridine in a human colon carcinoma cell line.
Chu E; Chu MY; Darnowski JW; Chen ZH; Pan BC; Chu SH
Cancer Res; 1992 Apr; 52(7):1729-36. PubMed ID: 1532344
[TBL] [Abstract][Full Text] [Related]
13. Peripheral-acting benzodiazepines inhibit the growth of human melanoma cells and potentiate the antiproliferative activity of recombinant human interferons.
Solowey WE; Pestka S; Spector S; Fryer RI; Fisher PB
J Interferon Res; 1990 Jun; 10(3):269-80. PubMed ID: 1696606
[TBL] [Abstract][Full Text] [Related]
14. N-(phosphonacetyl)-L-aspartate synergistically enhances the cytotoxicity of 5-fluorouracil/interferon-alpha-2a against human colon cancer cell lines.
Wadler S; Mao X; Bajaj R; Hallam S; Schwartz EL
Mol Pharmacol; 1993 Nov; 44(5):1070-6. PubMed ID: 8246910
[TBL] [Abstract][Full Text] [Related]
15. Irreversible cytotoxic effect of a novel lowly immunosuppressive antitumor fluorouridine derivative, UK-21.
Mori H; Nakayama K; Ishida R; Ito S; Nagai H; Koda A
Anticancer Drugs; 1997 Jun; 8(5):482-8. PubMed ID: 9215612
[TBL] [Abstract][Full Text] [Related]
16. Synergism and lack of cross-resistance between short-term and continuous exposure to fluorouracil in human colon adenocarcinoma cells.
Sobrero AF; Aschele C; Guglielmi AP; Mori AM; Melioli GG; Rosso R; Bertino JR
J Natl Cancer Inst; 1993 Dec; 85(23):1937-44. PubMed ID: 8230285
[TBL] [Abstract][Full Text] [Related]
17. Synergistic antiproliferative effect of interferons and azidothymidine on HL60 cells.
Nakae H; Asada S
Chem Pharm Bull (Tokyo); 1992 Mar; 40(3):821-2. PubMed ID: 1377102
[TBL] [Abstract][Full Text] [Related]
18. Synergistic efficacy of 3n-butyrate and 5-fluorouracil in human colorectal cancer xenografts via modulation of DNA synthesis.
Bras-Gonçalves RA; Pocard M; Formento JL; Poirson-Bichat F; De Pinieux G; Pandrea I; Arvelo F; Ronco G; Villa P; Coquelle A; Milano G; Lesuffleur T; Dutrillaux B; Poupon MF
Gastroenterology; 2001 Mar; 120(4):874-88. PubMed ID: 11231942
[TBL] [Abstract][Full Text] [Related]
19. The role of interferon-alpha as a modulator of fluorouracil and leucovorin.
Grem JL; van Groeningen CJ; Ismail AA; Johnston PG; Alexander HR; Allegra CJ
Eur J Cancer; 1995; 31A(7-8):1316-20. PubMed ID: 7577043
[TBL] [Abstract][Full Text] [Related]
20. A novel combination antimetabolite, TAS-102, exhibits antitumor activity in FU-resistant human cancer cells through a mechanism involving FTD incorporation in DNA.
Emura T; Suzuki N; Yamaguchi M; Ohshimo H; Fukushima M
Int J Oncol; 2004 Sep; 25(3):571-8. PubMed ID: 15289858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
